In addition to participation in meetings and discussions, the following products are to be delivered to NASA during the definition phase in support of preparation of the full study: > NASA IRB…
Active Grant For Research Awarded Last action
- Contract number
- 80NSSC21K0369
- Awardee
-
Beth Israel Deaconess Medical Center, Inc. UEI C1CPANL3EWK4
- Awarding agency
-
Shared Services Center
National Aeronautics and Space Administration
- Obligated
- $368,754
Award facts
- Contract value 47% obligated
- $784,445.00 Current and potential, with all options
- Completion date 79% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Other
- Place of performance
- Boston, MA 02215, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $75,000 | |
| Funding Only Action | $145,000 | |
| Funding Only Action | $25,000 | |
| Additional Work (new agreement, FAR part 6 applies) | $40,000 | |
| Additional Work (new agreement, FAR part 6 applies) | $10,000 | |
| Funding Only Action | $43,511 | |
| Funding Only Action | $10,000 | |
| Other Administrative Action | $0 | |
| Original award | $20,243 |
About this award
Beth Israel Deaconess Medical Center, Inc. (BIDMC), a Harvard Medical School-affiliated academic medical center in Boston, Massachusetts, received a $784,445 research grant award from the National Aeronautics and Space Administration (NASA) on February 1, 2021. This grant supports a definition phase study investigating resveratrol and electrical muscle stimulation as countermeasures to preserve sensorimotor function during a 60-day head-down bedrest protocol. The award carries an ultimate completion date of April 30, 2028 and was made on an unrestricted, non-set-aside basis. During the definition phase, BIDMC is responsible for developing and submitting an Institutional Review Board protocol to NASA, conducting feasibility assessments, and participating in meetings and discussions to prepare for the full study.
The research addresses a critical concern in space medicine and extended bed rest scenarios, where microgravity and immobilization lead to sensorimotor and musculoskeletal deconditioning. BIDMC's expertise in translational biomedical research and clinical interventions positions it well to conduct this sophisticated investigation, which bridges fundamental science with practical applications for astronaut health and rehabilitation protocols. The grant represents NASA's commitment to understanding and mitigating physiological challenges associated with prolonged spaceflight and immobilization.
Description
In addition to participation in meetings and discussions, the following products are to be delivered to NASA during the definition phase in support of preparation of the full study: > NASA IRB protocol development and submission > feasibility
Quick answers
Who was awarded contract 80NSSC21K0369?
80NSSC21K0369 was awarded to Beth Israel Deaconess Medical Center, Inc. by Shared Services Center (National Aeronautics and Space Administration) on February 1, 2021.
How much is contract 80NSSC21K0369 worth?
The government has obligated $368,754 on 80NSSC21K0369. Its current value, with exercised options, is $784,445.
Was contract 80NSSC21K0369 competed?
The extent of competition for 80NSSC21K0369 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award